HONG KONG—A flurry of Chinese companies, including a drug maker and a real-estate developer, launched Hong Kong initial public offerings seeking to raise as much as roughly US$1.2 billion and capitalize on recent gains in the city's stock market.. Luye Pharma Group Ltd., partly owned by a group of private-equity firms, is seeking to raise up to US$764 million in the biggest of the Hong Kong IPOs launched in recent weeks. Hong Kong's benchmark Hang Seng Index is up 5% since the start of May.